These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 17233855

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Post-partum hemorrhage: new therapeutic options].
    Franchini M.
    Recenti Prog Med; 2007 Jan; 98(1):7-11. PubMed ID: 17345873
    [Abstract] [Full Text] [Related]

  • 3. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.
    Franchini M, Franchi M, Bergamini V, Salvagno GL, Montagnana M, Lippi G.
    Semin Thromb Hemost; 2008 Feb; 34(1):104-12. PubMed ID: 18393147
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia].
    Levi M, Friederich PW, van der Meer J.
    Ned Tijdschr Geneeskd; 2002 Dec 28; 146(52):2534-7. PubMed ID: 12532665
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Intraoperative use of recombinant activated factor VII (rFVIIa).
    De Gasperi A.
    Minerva Anestesiol; 2006 Jun 28; 72(6):489-94. PubMed ID: 16682921
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.
    Pediatr Hematol Oncol; 2008 Jun 28; 25(4):301-11. PubMed ID: 18484474
    [Abstract] [Full Text] [Related]

  • 12. Immunological aspects of recombinant factor VIIa (rFVIIa) in clinical use.
    Nicolaisen EM, Hansen LL, Poulsen F, Glazer S, Hedner U.
    Thromb Haemost; 1996 Aug 28; 76(2):200-4. PubMed ID: 8865531
    [Abstract] [Full Text] [Related]

  • 13. Use of recombinant activated factor VII for intractable bleeding in patients without hemophilia: A developing country tertiary care center's experience.
    Musallam KM, Saad GS, Majdalani MN, Muwakkit SA, Bou-Khalil PK, Aoun EG, Sawaya RA, Khalil I, Taher AT.
    Clin Appl Thromb Hemost; 2010 Dec 28; 16(6):658-62. PubMed ID: 19671562
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
    Dunkley S, Phillips L, McCall P, Brereton J, Lindeman R, Jankelowitz G, Cameron P.
    Ann Thorac Surg; 2008 Mar 28; 85(3):836-44. PubMed ID: 18291152
    [Abstract] [Full Text] [Related]

  • 18. An open non-randomized study of recombinant activated factor VII in major postpartum haemorrhage.
    Ahonen J, Jokela R, Korttila K.
    Acta Anaesthesiol Scand; 2007 Aug 28; 51(7):929-36. PubMed ID: 17488316
    [Abstract] [Full Text] [Related]

  • 19. [Using recombinant activated coagulation factor VII (NovoSeven) in obstetrics].
    Pekhlivanov B, Milchev N, Abrashev B.
    Akush Ginekol (Sofiia); 2003 Aug 28; 42(6):7-9. PubMed ID: 15067806
    [Abstract] [Full Text] [Related]

  • 20. Use of recombinant activated factor VII in a case of severe postpartum haemorrhage.
    Verre M, Bossio F, Mammone A, Piccirillo M, Tancioni F, Varano M.
    Minerva Ginecol; 2006 Feb 28; 58(1):81-4. PubMed ID: 16498374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.